Patent US4557724A successfully refreshed from Google Patents.
US4557724A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Apparatus and methods for minimizing cellular adhesion on peritoneal injection catheters
Assignee: University of Utah Research Foundation Inc
•
Filing: 1983-08-12
•
Granted: 1985-12-10
•
Expires: 2003-08-12
Abstract
Abstract The present invention is directed to a subcutaneous peritoneal injection catheter apparatus and methods which minimizes catheter obstruction during use. The apparatus includes a receiving chamber or reservoir having a relatively small internal volume while employing a penetrable membrane and relatively enlarged target surface area. The reservoir is interconnected with the peritoneal cavity by a hollow stem. The penetrable membrane accommodates a hollow needle being inserted into the receiving reservoir and is configurated with a dome-like profile so that the membrane may also be depressed to expel insulin from the receiving reservoir into the peritoneal cavity in a direction generally toward the mesenteric peritoneal membrane. The portion of the apparatus which is in the peritoneal cavity is preferably constructed of, or coated with, a material which is capable of minimizing the adhesion of cells and the growth of bacteria on that portion of the apparatus. In a presently preferred embodiment of the subcutaneous peritoneal injection catheter, the portion of the catheter to be within the peritoneal cavity is constructed of a polyurethane material, and this polyurethane material is then coated with a solution of polyurethane and poly(ethylene glycol) in a suitable solvent.
Inventors
- 👤 Donald E. Gregonis
- 👤 Robert L. Stephen
- 👤 Dennis L. Coleman
- 👤 Stephen K. Hunter
- 👤 Barry K. Hanover
- 👤 Jeffrey J. Harrow
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-22 23:28
CPC Classifications
A; A61; A61M; A61M39/00; A61M39/02; A61M39/0208
Claims Analysis
Total Claims: 39
Claim 1
Independent Claim
126 words
A subcutaneously implantable injection conduit for injecting a drug into a peritoneal cavity, comprising: a hollow receptacle for receiving the drug, the hollow receptacle having a penetrable portion; a hollow stem having a proximal end and a distal end, the proximal end of the stem being attached to the receptacle such that the stem forms a passageway extending from the chamber; a diametrally enlarged flange attached to the stem such that, when the conduit is implanted under a layer of skin adjacent the peritoneal cavity and the flange is secured adjacent the parietal peritoneal membrane, the distal end of the hollow stem is positioned within the peritoneal cavity; and means for inhibiting cellular adhesion comprising a material coating on at least a portion of the conduit.
Claim 2
Dependent Claim
126 words
A subcutaneously implantable injection conduit for injecting a drug into a peritoneal cavity, comprising: a hollow receptacle for receiving the drug, the hollow receptacle having a penetrable portion; a hollow stem having a proximal end and a distal end, the proximal end of the stem being attached to the receptacle such that the stem forms a passageway extending from the chamber; a diametrally enlarged flange attached to the stem such that, when the conduit is implanted under a layer of skin adjacent the peritoneal cavity and the flange is secured adjacent the parietal peritoneal membrane, the distal end of the hollow stem is positioned within the peritoneal cavity; and means for inhibiting cellular adhesion comprising a material coating on at least a portion of the conduit.
Claim 3
Dependent Claim
24 words
A subcutaneously implantable injection conduit as defined in claim 1 wherein the means for inhibiting cellular adhesion comprises a material covering the enlarged flange.
Claim 4
Dependent Claim
16 words
A subcutaneously implantable injection conduit as defined in claim 2 wherein the material includes poly(ethylene glycol).
Claim 5
Dependent Claim
16 words
A subcutaneously implantable injection conduit as defined in claim 2 wherein the material includes poly(vinyl pyrrolidone).
Claim 6
Dependent Claim
16 words
A subcutaneously implantable injection conduit as defined in claim 2 wherein the material includes pyrolytic carbon.
Claim 7
Dependent Claim
17 words
A subcutaneously implantable injection conduit as defined in claim 2 wherein the material includes a polyacrylated hydrogel.
Claim 8
Dependent Claim
16 words
A subcutaneously implantable injection conduit as defined in claim 2 wherein the material includes poly(hydroxyethyl methacrylate).
Claim 9
Dependent Claim
16 words
A subcutaneously implantable injection conduit as defined in claim 2 wherein the material includes poly(vinyl alcohol).
Claim 10
Dependent Claim
15 words
A subcutaneously implantable injection conduit as defined in claim 2 wherein the material includes agarose.
Claim 11
Dependent Claim
16 words
A subcutaneously implantable injection conduit as defined in claim 2 wherein the material includes cross-linked dextrans.
Claim 12
Dependent Claim
126 words
A subcutaneously implantable injection conduit for injecting a drug into a peritoneal cavity, comprising: a hollow receptacle for receiving the drug, the hollow receptacle having a penetrable portion; a hollow stem having a proximal end and a distal end, the proximal end of the stem being attached to the receptacle such that the stem forms a passageway extending from the chamber; a diametrally enlarged flange attached to the stem such that, when the conduit is implanted under a layer of skin adjacent the peritoneal cavity and the flange is secured adjacent the parietal peritoneal membrane, the distal end of the hollow stem is positioned within the peritoneal cavity, said flange being comprised of a material capable of inhibiting cellular adhesion on the surface of the flange.
Claim 13
Dependent Claim
126 words
A subcutaneously implantable injection conduit for injecting a drug into a peritoneal cavity, comprising: a hollow receptacle for receiving the drug, the hollow receptacle having a penetrable portion; a hollow stem having a proximal end and a distal end, the proximal end of the stem being attached to the receptacle such that the stem forms a passageway extending from the chamber; a diametrally enlarged flange attached to the stem such that, when the conduit is implanted under a layer of skin adjacent the peritoneal cavity and the flange is secured adjacent the parietal peritoneal membrane, the distal end of the hollow stem is positioned within the peritoneal cavity, said flange being comprised of a material capable of inhibiting cellular adhesion on the surface of the flange.
Claim 14
Dependent Claim
20 words
A subcutaneously implantable injection conduit as defined in claim 11 wherein the material for inhibiting cellular adhesion includes poly(ethylene glycol).
Claim 15
Dependent Claim
20 words
A subcutaneously implantable injection conduit as defined in claim 11 wherein the material for inhibiting cellular adhesion includes poly(vinyl pyrrolidone).
Claim 16
Dependent Claim
20 words
A subcutaneously implantable injection conduit as defined in claim 11 wherein the material for inhibiting cellular adhesion includes pyrolytic carbon.
Claim 17
Dependent Claim
21 words
A subcutaneously implantable injection conduit as defined in claim 11 wherein the material for inhibiting cellular adhesion includes a polyacrylated hydrogel.
Claim 18
Dependent Claim
20 words
A subcutaneously implantable injection conduit as defined in claim 11 wherein the material for inhibiting cellular adhesion includes poly(hydroxyethyl methacrylate).
Claim 19
Dependent Claim
20 words
A subcutaneously implantable injection conduit as defined in claim 11 wherein the material for inhibiting cellular adhesion includes poly(vinyl alcohol).
Claim 20
Dependent Claim
19 words
A subcutaneously implantable injection conduit as defined in claim 11 wherein the material for inhibiting cellular adhesion includes agarose.
Claim 21
Dependent Claim
20 words
A subcutaneously implantable injection conduit as defined in claim 11 wherein the material for inhibiting cellular adhesion includes cross-linked dextrans.
Claim 22
Dependent Claim
220 words
A subcutaneously implantable injection conduit for injecting a drug into a peritoneal cavity, comprising: an injection receiver having a diametrally enlarged, convergent receiving surface and an opening in the receiving surface; a diametrally enlarged, penetrable cover across the receiving surface in spaced relationship therewith, the cover forming a receiving reservoir in combination with the receiving surface; a hollow stem having a proximal end and a distal end, the proximal end of the stem being attached to the injection receiver such that the stem forms a passageway extending from the opening in the receiving surface, the stem having a length sufficient that the stem penetrates the parietal peritoneal membrane and extends into the peritoneal cavity; a first diametrally enlarged flange attached to the stem such that, when the conduit is implanted under a layer of skin adjacent the peritoneal cavity and the first flange is secured adjacent the parietal peritoneal membrane, the distal end of the hollow stem is directed toward the mesenteric peritoneal membrane; a second diametrally enlarged flange, said second flange being attached to the stem in spaced relationship with the first flange; and a coating applied to the first and second enlarged flanges, and to the hollow stem, said coat being capable of inhibiting cellular adhesion to surfaces of the first and second flanges, and the hollow stem.
Claim 23
Dependent Claim
220 words
A subcutaneously implantable injection conduit for injecting a drug into a peritoneal cavity, comprising: an injection receiver having a diametrally enlarged, convergent receiving surface and an opening in the receiving surface; a diametrally enlarged, penetrable cover across the receiving surface in spaced relationship therewith, the cover forming a receiving reservoir in combination with the receiving surface; a hollow stem having a proximal end and a distal end, the proximal end of the stem being attached to the injection receiver such that the stem forms a passageway extending from the opening in the receiving surface, the stem having a length sufficient that the stem penetrates the parietal peritoneal membrane and extends into the peritoneal cavity; a first diametrally enlarged flange attached to the stem such that, when the conduit is implanted under a layer of skin adjacent the peritoneal cavity and the first flange is secured adjacent the parietal peritoneal membrane, the distal end of the hollow stem is directed toward the mesenteric peritoneal membrane; a second diametrally enlarged flange, said second flange being attached to the stem in spaced relationship with the first flange; and a coating applied to the first and second enlarged flanges, and to the hollow stem, said coat being capable of inhibiting cellular adhesion to surfaces of the first and second flanges, and the hollow stem.
Claim 24
Dependent Claim
20 words
A subcutaneously implantable injection conduit as defined in claim 20 wherein the material for inhibiting cellular adhesion includes poly(ethylene glycol).
Claim 25
Dependent Claim
20 words
A subcutaneously implantable injection conduit as defined in claim 20 wherein the material for inhibiting cellular adhesion includes poly(vinyl pyrrolidone).
Claim 26
Dependent Claim
20 words
A subcutaneously implantable injection conduit as defined in claim 20 wherein the material for inhibiting cellular adhesion includes pyrolytic carbon.
Claim 27
Dependent Claim
21 words
A subcutaneously implantable injection conduit as defined in claim 20 wherein the material for inhibiting cellular adhesion includes a polyacrylated hydrogel.
Claim 28
Dependent Claim
20 words
A subcutaneously implantable injection conduit as defined in claim 20 wherein the material for inhibiting cellular adhesion includes poly(hydroxyethyl methacrylate).
Claim 29
Dependent Claim
20 words
A subcutaneously implantable injection conduit as defined in claim 20 wherein the material for inhibiting cellular adhestion includes poly(vinyl alcohol).
Claim 30
Dependent Claim
19 words
A subcutaneously implantable injection conduit as defined in claim 20 wherein the material for inhibiting cellular adhesion includes agarose.
Claim 31
Dependent Claim
20 words
A subcutaneously implantable injection conduit as defined in claim 20 wherein the material for inhibiting cellular adhesion includes cross-linked dextrans.
Claim 32
Independent Claim
137 words
A method for manufacturing a peritoneal injection catheter, the method comprising the steps of: obtaining an injection conduit, comprising: a shallow vessel having a penetrable membrane; a hollow stem having a proximal end and a distal end, the proximal end of the stem being attached to the vessel such that the stem forms a passageway extending from the vessel; and a diametrally enlarged flange attached to the stem such that, when the conduit is implanted underneath a layer of skin adjacent the peritoneal cavity and the flange is secured adjacent the parietal peritoneal membrane, the distal end of the hollow stem is positioned within the peritoneal cavity; and coating the flange and the hollow stem of the injection catheter with a material capable of inhibiting cellular adhesion on the surfaces of the flange and the hollow stem.
Claim 33
Independent Claim
137 words
A method for manufacturing a peritoneal injection catheter, the method comprising the steps of: obtaining an injection conduit, comprising: a shallow vessel having a penetrable membrane; a hollow stem having a proximal end and a distal end, the proximal end of the stem being attached to the vessel such that the stem forms a passageway extending from the vessel; and a diametrally enlarged flange attached to the stem such that, when the conduit is implanted underneath a layer of skin adjacent the peritoneal cavity and the flange is secured adjacent the parietal peritoneal membrane, the distal end of the hollow stem is positioned within the peritoneal cavity; and coating the flange and the hollow stem of the injection catheter with a material capable of inhibiting cellular adhesion on the surfaces of the flange and the hollow stem.
Claim 34
Dependent Claim
19 words
A method for manufacturing a peritoneal injection catheter as defined in claim 29 where the coating includes poly(ethylene glycol).
Claim 35
Independent Claim
155 words
A method for manufacturing a peritoneal injection catheter, the method comprising the steps of: obtaining an injection conduit, comprising: a shallow vessel having a penetrable membrane; a hollow stem having a proximal end and a distal end, the proximal end of the stem being attached to the vessel such that the stem forms a passageway extending from the vessel; and a diametrally enlarged flange attached to the stem such that, when the conduit is implanted underneath a layer of skin adjacent the peritoneal cavity and the flange is secured adjacent the parietal peritoneal membrane, the distal end of the hollow stem is positioned within the peritoneal cavity, said flange being comprised of a polymeric material; preparing a solution of the polymeric material from which the flange is comprised and a material capable of inhibiting cellular adhesion in a suitable solvent; and coating the flange and the hollow stem of the injection catheter with the solution.
Claim 36
Independent Claim
155 words
A method for manufacturing a peritoneal injection catheter, the method comprising the steps of: obtaining an injection conduit, comprising: a shallow vessel having a penetrable membrane; a hollow stem having a proximal end and a distal end, the proximal end of the stem being attached to the vessel such that the stem forms a passageway extending from the vessel; and a diametrally enlarged flange attached to the stem such that, when the conduit is implanted underneath a layer of skin adjacent the peritoneal cavity and the flange is secured adjacent the parietal peritoneal membrane, the distal end of the hollow stem is positioned within the peritoneal cavity, said flange being comprised of a polymeric material; preparing a solution of the polymeric material from which the flange is comprised and a material capable of inhibiting cellular adhesion in a suitable solvent; and coating the flange and the hollow stem of the injection catheter with the solution.
Claim 37
Dependent Claim
23 words
A method for manufacturing a peritoneal injection catheter as defined in claim 31 where the solution comprises polyurethane, poly(ethylene glycol), and dimethyl acetimide.
Claim 38
Independent Claim
210 words
A method for minimizing cellular adhesion on a catheter, the method comprising the steps of: obtaining an injection conduit, comprising: a shallow vessel having a penetrable membrane; a hollow stem having a proximal end and a distal end, the proximal end of the stem being attached to the vessel such that the stem forms a passageway extending from the vessel; and a diametrally enlarged flange attached to the stem such that, when the conduit is implanted underneath a layer of skin adjacent the peritoneal cavity and the flange is secured adjacent the parietal peritoneal membrane, the distal end of the hollow stem is positioned within the peritoneal cavity; coating the flange and the hollow stem of the injection catheter with a material capable of inhibiting cellular adhesion on the surfaces of the flange and the hollow stem; and implanting the injection conduit underneath a layer of skin adjacent the peritoneal cavity with the membrane being generally parallel to the skin, the hollow stem penetrating the parietal peritoneal membrane and extending into the peritoneal cavity, the diametrally enlarged flange being secured adjacent the parietal peritoneal membrane, the distal end of the hollow stem being directed toward the mesenteric peritoneal membrane, and the passageway communicating between the vessel and the peritoneal cavity.
Claim 39
Independent Claim
210 words
A method for minimizing cellular adhesion on a catheter, the method comprising the steps of: obtaining an injection conduit, comprising: a shallow vessel having a penetrable membrane; a hollow stem having a proximal end and a distal end, the proximal end of the stem being attached to the vessel such that the stem forms a passageway extending from the vessel; and a diametrally enlarged flange attached to the stem such that, when the conduit is implanted underneath a layer of skin adjacent the peritoneal cavity and the flange is secured adjacent the parietal peritoneal membrane, the distal end of the hollow stem is positioned within the peritoneal cavity; coating the flange and the hollow stem of the injection catheter with a material capable of inhibiting cellular adhesion on the surfaces of the flange and the hollow stem; and implanting the injection conduit underneath a layer of skin adjacent the peritoneal cavity with the membrane being generally parallel to the skin, the hollow stem penetrating the parietal peritoneal membrane and extending into the peritoneal cavity, the diametrally enlarged flange being secured adjacent the parietal peritoneal membrane, the distal end of the hollow stem being directed toward the mesenteric peritoneal membrane, and the passageway communicating between the vessel and the peritoneal cavity.
References Cited (Backward Citations)
US3137299A
Cited
US3310051A
Cited
US3396727A
Cited
US3540451A
Cited
US3633585A
Cited
US3640269A
Cited
US3580983A
Cited
US3783868A
Cited
US3765414A
Cited
US3815577A
Cited
US3927242A
Cited
US3818511A
Cited
US3861396A
Cited
US4026296A
Cited
US4160454A
Cited
US4054139A
Cited
FR2390940A1
Cited
US4184497A
Cited
US4220153A
Cited
US4190040A
Cited
US4190048A
Cited
US4256102A
Cited
GB2056282A
Cited
US4253463A
Cited
US4411795A
Cited
GB2072514A
Cited
GB2073024A
Cited
US4368737A
Cited
US4400169A
Cited
US4405305A
Cited
US4490137A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1988-12-09 | 1989-06-10 | 1989-12-10 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1992-12-09 | 1993-06-10 | 1993-12-10 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1996-12-09 | 1997-06-10 | 1997-12-10 | $7700.00 | Window Closed / Lapsed |